前列腺动脉栓塞术治疗良性前列腺增生的疗效与安全性:UK-ROPE观察性研究及与经尿道前列腺电切术的倾向性匹配比较
UK-ROPE研究纳入305例患者(PAE 216例,TURP 89例),PAE术后12个月IPSS中位改善10分,TURP改善15分;倾向性匹配65对分析未证明PAE非劣于TURP。
要点
- PAE可显著改善BPH相关LUTS,12个月IPSS中位改善10分,但劣于TURP的15分。
- 倾向性匹配分析未证明PAE在IPSS和生活质量改善方面非劣于TURP。
核心结论
- PAE可临床且统计学显著改善症状和生活质量,但部分改善程度不如TURP。
- PAE安全且恢复日常活动更快,可减少住院时间和入院需求,对考虑替代TURP的患者可能非常有益。
- PAE是高级栓塞技术,需由经过培训和督导的经验丰富介入放射科医生实施。
- 鼓励使用锥形束CT以提高操作者信心并减少非靶栓塞。
- PAE在治疗路径中位于药物和手术之间,便于根据患者症状、需求和解剖变异个体化选择。
研究设计与样本
- UK-ROPE研究为英国介入放射学会、英国泌尿外科学会和NICE联合发起的观察性研究。
- 研究招募英国17个泌尿/介入放射中心的305例患者,其中216例接受PAE,89例接受TURP。
- 主要结局为PAE组术后12个月IPSS改善和PAE术后并发症数据。
- 采用倾向性评分匹配患者对,对PAE与TURP的IPSS改善进行非劣性分析。
- 临床结果和泌尿系统测量在临床中心进行,IPSS等问卷结果由患者直接邮寄至管理研究的研究单位。
主要发现
- PAE术后12个月IPSS较基线中位改善10分。
- TURP术后12个月IPSS中位改善15分。
- 倾向性评分分析形成65对匹配紧密的PAE和TURP患者,在IPSS和生活质量改善方面无证据表明PAE非劣于TURP。
- PAE组术后12个月最大尿流率和前列腺体积缩小有统计学显著改善。
- PAE再手术率12个月前为5%,12个月后为15%(总计20%),并发症率低。
关键数值与推荐
- 216例PAE患者中,1例脓毒症,1例需输血,4例局部动脉夹层,4例腹股沟血肿。
- 2例非靶栓塞表现为自限性阴茎溃疡。
- 80%的TURP病例需至少住院1晚,多数需2晚。
- PAE术后12个月IPSS中位改善10分,TURP为15分。
临床怎么用
- PAE可作为药物与手术之间的治疗选择,根据患者症状、需求和解剖变异个体化制定方案。
- PAE应由经过培训和督导的经验丰富介入放射科医生实施。
- 鼓励使用锥形束CT提高操作者信心并减少非靶栓塞。
- PAE日间手术比例高、恢复日常活动快,适合重视缩短住院时间的患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To assess the efficacy and safety of prostate artery embolization (PAE) for lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) and to conduct an indirect comparison of PAE with transurethral resection of the prostate (TURP). PATIENTS AND METHODS: As a joint initiative between the British Society of Interventional Radiologists, the British Association of Urological Surgeons and the National Institute for Health and Care Excellence, we conducted the UK Register of Prostate Embolization (UK-ROPE) study, which recruited 305 patients across 17 UK urological/interventional radiology centres, 216 of whom underwent PAE and 89 of whom underwent TURP. The primary outcomes were International Prostate Symptom Score (IPSS) improvement in the PAE group at 12 months post-procedure, and complication data post-PAE. We also aimed to compare IPSS score improvements between the PAE and TURP groups, using non-inferiority analysis on propensity-score-matched patient pairs. The clinical results and urological measurements were performed at clinical sites. IPSS and other questionnaire-based results were mailed by patients directly to the trial unit managing the study. All data were uploaded centrally to the UK-ROPE study database. RESULTS: The results showed that PAE was clinically effective, producing a median 10-point IPSS improvement from baseline at 12 months post-procedure. PAE did not appear to be as effective as TURP, which produced a median 15-point IPSS score improvement at 12 months post-procedure. These findings are further supported by the propensity score analysis, in which we formed 65 closely matched pairs of patients who underwent PAE and patients who underwent TURP. In terms of IPSS and quality-of-life (QoL) improvement, there was no evidence of PAE being non-inferior to TURP. Patients in the PAE group had a statistically significant improvement in maximum urinary flow rate and prostate volume reduction at 12 months post-procedure. PAE had a reoperation rate of 5% before 12 months and 15% after 12 months (20% total rate), and a low complication rate. Of 216 patients, one had sepsis, one required a blood transfusion, four had local arterial dissection and four had a groin haematoma. Two patients had non-target embolization that presented as self-limiting penile ulcers. Additional patient-reported outcomes, pain levels and return to normal activities were very encouraging for PAE. Seventy-one percent of PAE cases were performed as outpatient or day cases. In contrast, 80% of TURP cases required at least 1 night of hospital stay, and the majority required 2 nights. CONCLUSION: Our results indicate that PAE provides a clinically and statistically significant improvement in symptoms and QoL, although some of these improvements were greater in the TURP arm. The safety profile and quicker return to normal activities may be seen as highly beneficial by patients considering PAE as an alternative treatment to TURP, with the concomitant advantages of reduced length of hospital stay and need for admission after PAE. PAE is an advanced embolization technique demanding a high level of expertise, and should be performed by experienced interventional radiologists who have been trained and proctored appropriately. The use of cone-beam computed tomography is encouraged to improve operator confidence and minimize non-target embolizations. The place of PAE in the care pathway is between that of drugs and surgery, allowing the clinician to tailor treatment to individual patients' symptoms, requirements and anatomical variation.
引用
- Ray AF, Powell J, Speakman MJ, et al. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study). BJU Int. 2018. PMID: 29645352. doi:10.1111/bju.14249
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。